The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab

Autores: Forero-Castro, Maribel; Robledo, Cristina; Lumbreras, Eva; Benito, Rocio; Hernandez-Sanchez, Jesus M.; Hernandez-Sanchez, Maria; Garcia, Juan L.; Corchete-Sanchez, Luis A.; Tormo, Mar; Barba, Pere; Menarguez, Javier; Ribera, Jordi; Grande García, Carlos; Escoda, Lourdes; Olivier, Carmen; Carrillo, Estrella; Garcia de Coca, Alfonso; Ribera, Josep-Maria; Hernandez-Rivas, Jesus M.